Sanofi says U.S. probing Plavix disclosures to FDA

PARIS (Reuters) - The U.S. Department of Justice (DoJ) is investigating disclosures to the Food & Drug Administration (FDA) about the variable response that certain patients may have to blood-thinner Plavix, Sanofi said in its annual report.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Clopidogrel | Health | Plavix